🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 19 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 04/04/2013 | 16,13 | 16,19 | 15,61 | 16,18 | +0,74% | 3,60% | 153.567 |
| 03/04/2013 | 16,60 | 16,79 | 15,68 | 16,06 | -2,83% | 6,73% | 180.498 |
| 02/04/2013 | 16,57 | 16,78 | 16,44 | 16,53 | +0,15% | 2,07% | 184.986 |
| 01/04/2013 | 16,71 | 16,98 | 16,33 | 16,50 | -0,75% | 3,88% | 140.904 |
| 28/03/2013 | 16,49 | 16,80 | 16,21 | 16,63 | +0,68% | 3,56% | 184.986 |
| 27/03/2013 | 16,11 | 16,54 | 15,90 | 16,51 | +1,46% | 3,95% | 144.751 |
| 26/03/2013 | 16,22 | 16,28 | 15,99 | 16,28 | +1,20% | 1,81% | 153.728 |
| 25/03/2013 | 16,06 | 16,43 | 15,92 | 16,08 | +0,43% | 3,15% | 161.582 |
| 22/03/2013 | 15,25 | 16,06 | 15,17 | 16,01 | +5,12% | 5,81% | 321.402 |
| 21/03/2013 | 15,31 | 15,41 | 15,04 | 15,23 | -0,53% | 2,44% | 126.797 |
| 20/03/2013 | 14,71 | 15,61 | 14,69 | 15,32 | +4,51% | 6,28% | 311.463 |
| 19/03/2013 | 14,35 | 14,69 | 14,35 | 14,65 | +2,40% | 2,39% | 123.591 |
| 18/03/2013 | 14,41 | 14,44 | 14,12 | 14,31 | -1,42% | 2,21% | 82.715 |
| 15/03/2013 | 14,42 | 14,54 | 14,27 | 14,52 | +0,74% | 1,82% | 256.159 |
| 14/03/2013 | 14,16 | 14,48 | 13,52 | 14,41 | +5,67% | 6,78% | 296.395 |
| 13/03/2013 | 14,02 | 14,02 | 13,56 | 13,64 | -2,89% | 3,25% | 64.441 |
| 12/03/2013 | 14,03 | 14,16 | 13,73 | 14,04 | -0,31% | 3,07% | 130.965 |
| 11/03/2013 | 14,32 | 14,45 | 13,97 | 14,09 | -1,70% | 3,31% | 113.492 |
| 08/03/2013 | 14,33 | 14,35 | 13,89 | 14,33 | +0,92% | 3,18% | 221.535 |
| 07/03/2013 | 14,05 | 14,20 | 13,94 | 14,20 | +0,75% | 1,86% | 97.142 |
| 06/03/2013 | 13,77 | 14,10 | 13,64 | 14,09 | +2,92% | 3,31% | 166.231 |
| 05/03/2013 | 13,28 | 13,72 | 13,18 | 13,69 | +3,93% | 4,09% | 147.797 |
| 04/03/2013 | 12,86 | 13,30 | 12,84 | 13,18 | +2,38% | 3,59% | 103.874 |
| 01/03/2013 | 12,68 | 12,99 | 12,68 | 12,87 | +0,44% | 2,46% | 172.483 |
| 28/02/2013 | 12,83 | 12,97 | 12,68 | 12,81 | -0,15% | 2,24% | 114.935 |
| 27/02/2013 | 12,76 | 12,94 | 12,73 | 12,83 | +0,34% | 1,66% | 107.561 |
| 26/02/2013 | 12,86 | 13,06 | 12,61 | 12,79 | -0,10% | 3,54% | 106.119 |
| 25/02/2013 | 13,30 | 13,31 | 12,76 | 12,80 | -3,30% | 4,08% | 215.764 |
| 22/02/2013 | 13,04 | 13,29 | 12,84 | 13,24 | +2,27% | 3,44% | 100.989 |
| 21/02/2013 | 13,23 | 13,23 | 12,84 | 12,94 | -3,13% | 2,97% | 168.636 |